19,374 Stryker Corporation $SYK Shares Acquired by Eagle Rock Investment Company LLC

Eagle Rock Investment Company LLC increased its position in shares of Stryker Corporation (NYSE:SYK) by 63.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 49,939 shares of the medical technology company’s stock after acquiring an additional 19,374 shares during the quarter. Stryker makes up approximately 1.6% of Eagle Rock Investment Company LLC’s holdings, making the stock its 18th biggest holding. Eagle Rock Investment Company LLC’s holdings in Stryker were worth $13,753,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Gables Capital Management Inc. acquired a new stake in shares of Stryker during the second quarter worth $25,000. Kilter Group LLC purchased a new stake in shares of Stryker in the second quarter valued at $25,000. Cornerstone Financial Management LLC increased its stake in Stryker by 66.0% in the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after purchasing an additional 31 shares during the last quarter. Highland Investment Advisors LLC acquired a new position in Stryker in the second quarter valued at $25,000. Finally, Compass Financial Management LLC acquired a new position in Stryker in the second quarter valued at $27,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on SYK shares. Sanford C. Bernstein reiterated a “market perform” rating on shares of Stryker in a research report on Wednesday, October 7th. Royal Bank Of Canada lowered their price target on Stryker from $435.00 to $420.00 and set an “outperform” rating for the company in a report on Friday, July 31st. BMO Capital Markets reaffirmed an “outperform” rating and set a $317.00 price objective on shares of Stryker in a research note on Wednesday, September 9th. BTIG Research cut their price objective on shares of Stryker from $358.00 to $316.00 and set a “buy” rating on the stock in a report on Monday, October 12th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Stryker from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $369.00.

Insider Buying and Selling at Stryker

In other news, insider Dylan Crotty sold 441 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $328.61, for a total value of $144,917.01. Following the transaction, the insider directly owned 6,102 shares in the company, valued at $2,005,178.22. This trade represents a 6.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Debra King sold 826 shares of Stryker stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the transaction, the insider directly owned 6,210 shares in the company, valued at $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 351,267 shares of company stock valued at $118,197,701. Company insiders own 4.60% of the company’s stock.

Stryker Stock Down 2.3%

Shares of SYK opened at $297.30 on Thursday. Stryker Corporation has a fifty-two week low of $267.00 and a fifty-two week high of $392.55. The company’s fifty day moving average is $296.53 and its two-hundred day moving average is $312.13. The firm has a market cap of $114.03 billion, a PE ratio of 30.81, a price-to-earnings-growth ratio of 1.96 and a beta of 0.78. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. The business had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same period in the prior year, the firm posted $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts forecast that Stryker Corporation will post 14.93 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s payout ratio is 36.48%.

Stryker Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.